For the latest COVID-19 campus news and resources, visit umassmed.edu/coronavirus.

Buscar Close Search
Buscar Close Search
Page Menu

BRIDGE Innovation & Business Development Team

bridge-org.jpg


Executive Vice Chancellor – BRIDGE Innovation & Business Development 

The office of EVC - BRIDGE Innovation & Business Development provides leadership, vision and comprehensive business strategy to commercialize intellectual property portfolio and lead business transactions for UMass Chan Medical School and its various affiliates. We are eager to work with variety of external entities, including investors, established as well as new pharma/biotech companies, incubators and other research organizations. 

The various functions including New Ventures, Operations, Transactions/IP Management report to this office and together enable establishment of NewCo spin-outs, alliances, licensing agreements and novel investment/collaboration structures in line with UMass Chan’s strategic goals.

Getting Results…

New Ventures

The New Ventures (NV) group is the first point of contact for UMass Chan researchers and external partners alike. This group is responsible for proactively scouting UMass Chan Medical School to identify and evaluate commercializable assets and platform technology and match them with potential partners in biotech, pharma and investor ecosystem. The New Venture team leads early structuring and negotiation up to term-sheet stage and works with Transaction team towards definitive contracts.

New Ventures Group A

Getting Results…
  • profile photo of Denise Karaoglu Hanzatian

    Denise Karaoglu Hanzatian, PhD

    Executive Director, New Ventures, Heads NV Group A

    Neuroscience, RNA Therapeutics Platform Technologies
Getting Results…
  • profile photo of Abbas Abdallah

    Abbas Abdallah, PhD

    Sr. Business Development Manager

    RNA Therapeutics Institute(RTI), Radiology
  • profile photo of Sylvia Bonilla, PhD

    Sylvia Bonilla, PhD

    Manager, New Ventures

    Gene Editing, Devices & Diagnostics

New Ventures Group Z

Getting Results…
  • profile photo of Huseyin Mehmet

    Huseyin Mehmet, PhD

    Executive Director, New Ventures, Heads NV Group Z

    Gene Therapy Platform Technologies, Metabolic Disease
Getting Results…
  • profile photo of Carole Burns

    Carole Burns, PhD, Patent Agent

    Director, New Ventures

    Diagnostics, Immunology, Oncology
  • profile photo of Ozge Yildiz, PhD

    Ozge Yildiz, PhD

    Manager, New Ventures

    Gene Therapies, Rare Diseases

Business Development Operations & Accounting

Business Development Operations works across all functions of the Business Development team (New ventures, Transactions, Finance) to ensure operational effectiveness, cross-functional co-operation/deal flow and lead initiatives that ensure wider and systematic outreach to enable effective commercialization.

Getting Results…

Business Development Accounting is responsible for reporting, budgeting, royalty revenue and distribution, database management, accounts payable/receivable, invoicing, financial analysis, operational data analysis, audit support, and information systems support for business development

Getting Results…

Transactions

Transactions provides end-to-end contracting process and produces legal documents/solutions for variety of license and sponsored research agreements (SRA), material transfer agreements (MTAs), confidentiality agreements (CDAs) and Core services agreements to facilitate needs of UMass Chan researchers, new venture team & external partners. Transactions team works in close coordination with New Ventures and IP management team.

Getting Results…
Getting Results…

IP Management

This team is responsible for receiving Invention Disclosures and filing/maintenance of UMMS IP portfolio including core IP, out and in-licensed IP and collaborative agreements and help drive they key actions and decisions required to build and defend a strong IP portfolio with broad coverage of UMMS inventions

Getting Results…
  • profile photo of Patricia Wynne, PhD, MBA, Patent Agent

    Patricia Wynne, PhD, MBA, Patent Agent

    Director, Intellectual Property

Getting Results…